Welcome to our dedicated page for Gentherm news (Ticker: THRM), a resource for investors and traders seeking the latest updates and insights on Gentherm stock.
Gentherm Inc. (NASDAQ: THRM) is a global leader in thermal management and pneumatic comfort technologies, primarily serving the automotive and medical industries. The company is renowned for its innovative thermal solutions, which include heating, cooling, and ventilating devices designed to enhance comfort and energy efficiency. With a robust patent portfolio and a dedicated team of world-class scientists and engineers, Gentherm is committed to continuous innovation and improvement in thermal technology.
Gentherm's core business is divided into two main segments: Automotive and Medical. The Automotive segment, which constitutes the majority of the company's revenue, offers a wide range of climate comfort systems, battery performance solutions, cable systems, and automotive electronics and software. Gentherm's products in this segment include Climate Control Seats, heated seats, steering wheels, armrests, and other interior components. Their technology is highly regarded by major automotive manufacturers, making Gentherm a preferred supplier for many industry leaders.
The Medical segment focuses on patient temperature management solutions. Gentherm's medical products include systems for whole-body warming and cooling, such as the Blanketrol® and Astopad® systems, which are essential in maintaining normothermia and providing localized therapy. The company's recent partnerships, such as the expanded collaboration with SourceMark Medical, further solidify its position in the healthcare market.
Gentherm's latest innovation, WellSense, was unveiled at the 2024 Consumer Electronics Show (CES). This technology integrates heating, cooling, lumbar, and massage comfort effectors to enhance wellness and well-being in vehicles. WellSense leverages science-based physiology research and offers over-the-air (OTA) feature upgrades, positioning Gentherm at the forefront of health, wellness, comfort, and energy efficiency in the automotive industry.
Financially, Gentherm has shown strong performance, with record revenues and adjusted EBITDA in both Automotive and Medical segments for 2023. The company also secured significant new automotive awards, including the scalable ClimateSense® software for General Motors' future vehicle architectures. Gentherm continues to expand its global footprint with new facilities in Tangier, Morocco, and Monterrey, Mexico, as part of its Fit-for-Growth 2.0 initiatives aimed at driving revenue growth and margin expansion.
Gentherm (NASDAQ:THRM) announced its first-quarter 2023 financial results, reporting a record revenue of $363.6 million, a 35.9% increase from $267.7 million in Q1 2022. Automotive revenues rose 36.8% year over year, while new automotive awards secured totaled $480 million. Adjusted diluted earnings per share improved to $0.49, up from $0.41 in the same quarter last year. Despite these strong figures, GAAP diluted EPS decreased to $0.24 from $0.35 year-over-year. The company reaffirmed its full-year 2023 guidance, anticipating product revenues between $1.45 billion and $1.55 billion. Gentherm's gross margin faced a decline to 22.3% from 24.0%, attributed to inflation and the acquisition of Alfmeier.
FAQ
What is the current stock price of Gentherm (THRM)?
What is the market cap of Gentherm (THRM)?
What are Gentherm's main business segments?
What are some of Gentherm's key products in the automotive segment?
What recent innovations has Gentherm introduced?
How has Gentherm performed financially in recent years?
What is Gentherm's role in the medical industry?
Where is Gentherm expanding its global operations?
What is the purpose of Gentherm's Fit-for-Growth 2.0 initiatives?
Who are Gentherm's key partners in the medical segment?
What is the significance of Gentherm's WellSense technology?
How does Gentherm support its commitment to innovation?
